Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -150,943 | -109,576 | -66,161 | -178,407 | -120,197 |
| Depreciation Amortization | 4,786 | 3,012 | 1,427 | 2,184 | 821 |
| Accounts receivable | -7,928 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -1,215 | -3,171 | -2,016 | -1,380 | -3,425 |
| Other Working Capital | -16,918 | -16,286 | -5,796 | -169 | -4,947 |
| Other Operating Activity | 20,885 | 11,194 | 5,923 | 18,655 | 16,803 |
| Operating Cash Flow | $-151,333 | $-114,827 | $-66,623 | $-159,117 | $-110,945 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -156 | -49 | -49 | -2,363 | -1,270 |
| Purchase Of Investment | -90,329 | -46,668 | -27,993 | -242,811 | -97,662 |
| Sale Of Investment | 202,454 | 118,511 | 60,033 | 137,510 | 94,378 |
| Investing Cash Flow | $111,969 | $71,794 | $31,991 | $-107,664 | $-4,554 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 166,885 | N/A |
| Debt Repayment | 73,682 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 15,687 | 547 | 152 | 149,224 | 148,333 |
| Financing Cash Flow | $89,369 | $547 | $152 | $316,109 | $148,333 |
| Exchange Rate Effect | -26 | 9 | -37 | -78 | -9 |
| Beginning Cash Position | 118,737 | 118,737 | 118,737 | 69,487 | 69,487 |
| End Cash Position | 168,716 | 76,260 | 84,220 | 118,737 | 102,312 |
| Net Cash Flow | $49,979 | $-42,477 | $-34,517 | $49,250 | $32,825 |
| Free Cash Flow | |||||
| Operating Cash Flow | -151,333 | -114,827 | -66,623 | -159,117 | -110,945 |
| Capital Expenditure | -156 | -49 | -49 | -2,363 | -1,270 |
| Free Cash Flow | -151,489 | -114,876 | -66,672 | -161,480 | -112,215 |